Biofunctionalization of 3D Printed Porous Tantalum Using a Vancomycin–Carboxymethyl Chitosan Composite Coating to Improve Osteogenesis and Antibiofilm Properties
Source abstract
Abstract
3D-printed porous tantalum scaffold has been increasingly used in arthroplasty due to its bone-matching elastic modulus and good osteoinductive ability. However, the lack of antibacterial ability makes it difficult for tantalum to prevent the occurrence and development of periprosthetic joint infection. The difficulty and high cost of curing periprosthetic joint infection (PJI) and revision surgery limit the further clinical application of tantalum. Therefore, we fabricated vancomycin-loaded porous tantalum scaffolds by combining the chemical grafting of (3-aminopropyl)triethoxysilane (APTES) and the electrostatic assembly of carboxymethyl chitosan and vancomycin for the first time. Our in vitro experiments show that the scaffold achieves rapid killing of initially adherent bacteria and effectively prevents biofilm formation. In addition, our modification preserves the original excellent structure and biocompatibility of porous tantalum and promotes the generation of mineralized matrix and osteogenesis-related gene expression by mesenchymal stem cells on the surface of scaffolds. Through a rat subcutaneous infection model, the composite bioscaffold shows efficient bacterial clearance and inflammation control in soft tissue and creates an immune microenvironment suitable for tissue repair at an early stage. Combined with the economic friendliness and practicality of its preparation, this scaffold has great clinical application potential in the treatment of periprosthetic joint infection.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Orthopedic Infections and Treatments · Orthopaedic implants and arthroplasty · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopeadics, Xiangya Hospital Central South University, Changsha 410008, P. R. China
National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Changsha 410008, P. R. China
Centers for Disease Control and Prevention, Zhuzhou 412008, P. R. China
Department of Orthopeadics, The First Affiliated Hospital, Medical College of Zhejiang University, Hangzhou 311121, P. R. China
Funding
National Natural Science Foundation of China
References (56)
Show source-provided references
1. 10.3390/antibiotics909054710.3390/antibiotics9090547 ↗
2. 10.1016/S0140-6736(14)61798-010.1016/S0140-6736(14)61798-0 ↗
3. 10.1038/s41579-018-0019-y10.1038/s41579-018-0019-y ↗
4. 10.1007/s00281-011-0275-710.1007/s00281-011-0275-7 ↗
5. 10.1038/s41467-021-23069-010.1038/s41467-021-23069-0 ↗
6. 10.1093/femsre/fux01010.1093/femsre/fux010 ↗
7. 10.1016/j.mtbio.2022.10033010.1016/j.mtbio.2022.100330 ↗
8. 10.1021/acsnano.0c0804510.1021/acsnano.0c08045 ↗
9. 10.1021/acsami.1c0138910.1021/acsami.1c01389 ↗
10. 10.1016/j.arth.2020.12.00510.1016/j.arth.2020.12.005 ↗
11. 10.1016/S0140-6736(18)32344-410.1016/S0140-6736(18)32344-4 ↗
12. 10.1021/acsami.1c0751510.1021/acsami.1c07515 ↗
13. 10.1016/j.colsurfb.2021.11205510.1016/j.colsurfb.2021.112055 ↗
14. 10.1155/2021/289904310.1155/2021/2899043 ↗
15. 10.1016/j.msec.2015.01.00710.1016/j.msec.2015.01.007 ↗
16. 10.1016/j.msec.2020.11101810.1016/j.msec.2020.111018 ↗
17. 10.3390/ma1206098010.3390/ma12060980 ↗
18. 10.1302/0301-620X.101B3.BJJ-2018-0959.R110.1302/0301-620X.101B3.BJJ-2018-0959.R1 ↗
19. 10.1007/s00264-022-05353-w10.1007/s00264-022-05353-w ↗
20. 10.1302/0301-620X.99B9.BJJ-2016-1309.R110.1302/0301-620X.99B9.BJJ-2016-1309.R1 ↗
21. 10.1002/adhm.20210208710.1002/adhm.202102087 ↗
22. 10.1128/AAC.02012-2010.1128/AAC.02012-20 ↗
23. 10.1021/acsami.0c0723410.1021/acsami.0c07234 ↗
24. 10.1016/j.actbio.2018.10.03610.1016/j.actbio.2018.10.036 ↗
25. 10.3389/fbioe.2020.60307210.3389/fbioe.2020.603072 ↗
26. 10.1016/j.msec.2016.06.06710.1016/j.msec.2016.06.067 ↗
27. 10.1016/j.jmbbm.2010.07.00510.1016/j.jmbbm.2010.07.005 ↗
28. 10.3390/polym1401016510.3390/polym14010165 ↗
29. 10.1016/j.bioactmat.2020.01.00110.1016/j.bioactmat.2020.01.001 ↗
30. 10.1016/j.carbpol.2018.09.02310.1016/j.carbpol.2018.09.023 ↗
31. 10.1016/j.ijpharm.2020.11982910.1016/j.ijpharm.2020.119829 ↗
32. 10.1021/acs.biomac.1c0136810.1021/acs.biomac.1c01368 ↗
33. 10.1016/j.colsurfb.2020.11149210.1016/j.colsurfb.2020.111492 ↗
34. 10.1016/j.actbio.2020.07.04010.1016/j.actbio.2020.07.040 ↗
35. 10.1016/j.biomaterials.2018.10.03310.1016/j.biomaterials.2018.10.033 ↗
36. 10.1002/mabi.20210033810.1002/mabi.202100338 ↗
37. 10.3390/ma1410264710.3390/ma14102647 ↗
38. 10.1021/am300727v10.1021/am300727v ↗
39. 10.1016/j.jmbbm.2017.06.02210.1016/j.jmbbm.2017.06.022 ↗
40. 10.1016/j.msec.2020.11176110.1016/j.msec.2020.111761 ↗
41. 10.1021/acsami.1c1983410.1021/acsami.1c19834 ↗
42. 10.3390/ma1422690110.3390/ma14226901 ↗
43. 10.1016/j.apsb.2019.12.01410.1016/j.apsb.2019.12.014 ↗
44. 10.1002/adhm.20190137510.1002/adhm.201901375 ↗
45. 10.1016/j.ijbiomac.2018.09.13110.1016/j.ijbiomac.2018.09.131 ↗
46. 10.1016/j.jcis.2013.05.06010.1016/j.jcis.2013.05.060 ↗
47. 10.1016/j.colsurfb.2020.11108310.1016/j.colsurfb.2020.111083 ↗
48. 10.1002/jbm.b.3415110.1002/jbm.b.34151 ↗
49. 10.1021/acsami.6b0099810.1021/acsami.6b00998 ↗
50. 10.1016/j.molliq.2018.12.00310.1016/j.molliq.2018.12.003 ↗
51. 10.1016/j.actbio.2018.11.03910.1016/j.actbio.2018.11.039 ↗
52. 10.1016/j.ijbiomac.2018.04.04510.1016/j.ijbiomac.2018.04.045 ↗
53. 10.1016/j.ijbiomac.2020.05.16110.1016/j.ijbiomac.2020.05.161 ↗
54. 10.3390/biom1004065210.3390/biom10040652 ↗
55. 10.1016/j.biomaterials.2021.12112710.1016/j.biomaterials.2021.121127 ↗
56. 10.1016/j.actbio.2021.04.05210.1016/j.actbio.2021.04.052 ↗